Added to YB: 2024-11-06
Pitch date: 2024-11-04
1SXP.F [bullish]
SCHOTT Pharma AG & Co. KGaA
-48.08%
current return
Author Info
Octopus Value is a private investor focusing on quality companies with margin of safety Sign up for the newsletter.
Company Info
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
Market Cap
EUR 4.2B
Pitch Price
EUR 29.16
Price Target
36.49 (+138%)
Dividend
0.57%
EV/EBITDA
16.72
P/E
28.61
EV/Sales
4.62
Sector
Life Sciences Tools and Services
Category
growth
Schott Pharma AG - Quantitative Analysis
1SXP.F: Pharma packaging co. w/ 10% rev CAGR, margin expansion from HVS mix shift. FCF down on CapEx/WC, expected to improve. DCF shows 23% upside. Strong ROIC/ROE (15-20%). Risks: mgmt alignment, complex financials due to Schott AG ties. Rev growth 11-13% FY24, EBIT +24.8% CAGR since 2020.
Read full article (6 min)